Cargando…
COVID-19 Drug Treatment in China
PURPOSE OF REVIEW: An unprecedented outbreak of the novel coronavirus in China (COVID-19) occurred in December 2019, and then engulfed the entire world, presenting a significant and urgent threat to global health. Many research institutes have been involved in the development of drugs and vaccines a...
Autores principales: | Fan, Linzi, Jiang, Shuang, Yang, Xinrong, Wang, Zhibin, Yang, Chunjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302922/ https://www.ncbi.nlm.nih.gov/pubmed/32837851 http://dx.doi.org/10.1007/s40495-020-00218-5 |
Ejemplares similares
-
Combating devastating COVID-19 by drug repurposing
por: Pawar, Ashish Yashwantrao
Publicado: (2020) -
An Update on Current Therapeutic Drugs Treating COVID-19
por: Wu, Renyi, et al.
Publicado: (2020) -
Repurposing drugs during the COVID-19 pandemic and beyond
por: Ravi, Srividya, et al.
Publicado: (2021) -
Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment
por: Shi, Ke, et al.
Publicado: (2021) -
Traditional Chinese and Western Medicines Jointly Beat COVID-19 Pandemic
por: Qing, Guang-chao, et al.
Publicado: (2020)